Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Grimaldi

Showing results (301-310 of 410) with videos related to

Pageof 41
Sort By:
Minerva Chirurgica|June 1, 1994
[Primary hydatid cyst of the coracobrachial muscle. A clinical case]M Pochini, G Maggiulli, D Nardi, et al.
Neurology|July 17, 1999
Genetic heterogeneity in Italian families with familial hemiplegic migraineP Carrera, M Piatti, S Stenirri, et al.
Annals of Neurology|July 1, 1993
The human-severe combined immunodeficiency myasthenic mouse model: a new approach for the study of myasthenia gravisG Martino, B L DuPont, R L Wollmann, et al.
Cell Death Discovery|January 9, 2026
In vitro cytotoxic mechanisms of Pt(O,O'-acac)(γ-acac)(DMS): mitochondrial dysfunction and impaired autophagy in U251 cell lineL Gaiaschi, F De Luca, C R Girelli, et al.
Anti-Cancer Drugs|January 27, 2015
Vemurafenib beyond progression in a patient with metastatic melanoma: a case reportAntonio M Grimaldi, Ester Simeone, Marco Palla, et al.
Aging (Milan, Italy)|July 10, 2001
Neuroinflammation and the genetics of Alzheimer's disease: the search for a pro-inflammatory phenotypeC Franceschi, S Valensin, F Lescai, et al.
Journal of Viral Hepatitis|May 1, 1997
Human leucocyte interferon-alpha in chronic hepatitis C resistant to recombinant or lymphoblastoid interferon-alpha: a randomized controlled trialG B Gaeta, D Di Virgilio, G Russo, et al.
Bone Marrow Transplantation|December 1, 1989
Allogeneic bone marrow transplantation for multiple myelomaS Tura, M Cavo, G Rosti, et al.
Journal of Translational Medicine|December 6, 2017
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumabSilvana Morello, Mariaelena Capone, Claudia Sorrentino, et al.
Tumori|May 13, 2017
Pathogenesis, clinical manifestations and management of immune checkpoint inhibitors toxicityAlessandro Inno, Giulio Metro, Paolo Bironzo, et al.
Pageof 41

Showing results (301-310 of 410) with videos related to

Sort By:
Pageof 41
Minerva Chirurgica|June 1, 1994
[Primary hydatid cyst of the coracobrachial muscle. A clinical case]M Pochini, G Maggiulli, D Nardi, et al.
Neurology|July 17, 1999
Genetic heterogeneity in Italian families with familial hemiplegic migraineP Carrera, M Piatti, S Stenirri, et al.
Annals of Neurology|July 1, 1993
The human-severe combined immunodeficiency myasthenic mouse model: a new approach for the study of myasthenia gravisG Martino, B L DuPont, R L Wollmann, et al.
Cell Death Discovery|January 9, 2026
In vitro cytotoxic mechanisms of Pt(O,O'-acac)(γ-acac)(DMS): mitochondrial dysfunction and impaired autophagy in U251 cell lineL Gaiaschi, F De Luca, C R Girelli, et al.
Anti-Cancer Drugs|January 27, 2015
Vemurafenib beyond progression in a patient with metastatic melanoma: a case reportAntonio M Grimaldi, Ester Simeone, Marco Palla, et al.
Aging (Milan, Italy)|July 10, 2001
Neuroinflammation and the genetics of Alzheimer's disease: the search for a pro-inflammatory phenotypeC Franceschi, S Valensin, F Lescai, et al.
Journal of Viral Hepatitis|May 1, 1997
Human leucocyte interferon-alpha in chronic hepatitis C resistant to recombinant or lymphoblastoid interferon-alpha: a randomized controlled trialG B Gaeta, D Di Virgilio, G Russo, et al.
Bone Marrow Transplantation|December 1, 1989
Allogeneic bone marrow transplantation for multiple myelomaS Tura, M Cavo, G Rosti, et al.
Journal of Translational Medicine|December 6, 2017
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumabSilvana Morello, Mariaelena Capone, Claudia Sorrentino, et al.
Tumori|May 13, 2017
Pathogenesis, clinical manifestations and management of immune checkpoint inhibitors toxicityAlessandro Inno, Giulio Metro, Paolo Bironzo, et al.
Pageof 41